Dual inhibition of human rhinovirus 2A and 3C proteases by homophthalimides

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 4, 1998, Pages 916-920

  Wang, Q May ^a   Johnson, Robert B ^a   Jungheim, Louis N ^a   Cohen, Jeffrey D ^a   Villarreal, Elcira C ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOPHTHALIMIDE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS ENZYME;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG DESIGN; DRUG SYNTHESIS; ENZYME INHIBITION; ENZYME PURIFICATION; HUMAN RHINOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0031968180     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.4.916     Document Type: Article

References (21)

1. Birch, G. M., T. Black, S. K. Malcolm, M. T. Lai, R. E. Zimmerman, and S. R. Jaskunas. 1995. Purification of recombinant human rhinovirus 14 3C protease expressed in E. coli. Protein Expr. Purif. 6:609-618.
2. Clark, M. E., P. M. Liberian, A. J. Berg, and A. Dasgupta. 1993. Direct cleavage of human TATA-binding protein by poliovirus protease 3C in vivo and in vitro. Mol. Cell. Biol. 13:1232-1237.
3. Clark, M. E., T. Hammerle, E. Wimmer, and A. Dasgupta. 1991. Poliovirus proteinase 3C converts an active form of transcription factor HIC to an inactive form: a mechanism for inhibition of host cell polymerase III transcription by poliovirus. EMBO J. 10:2941-2947.
4. Cordingley, M. G., P. L. Callahan, V. V. Sardana, V. M. Garsky, and R. J. Colonno. 1990. Substrate requirements of human rhinovirus 3C protease fur peptide cleavage in vitro. J. Biol. Chem. 265:9062-9065.
5. Couch, R. B. 1990. Rhinoviruses, p. 607-629. In B. N. Fields and D. M. Knipe (ed.), Virology. Raven Press, New York, N.Y.
6. Heinz, B. A., J. Tang, J. M. Labus, F. W. Chadwell, S. W. Kaldor, and M. Hammond. 1996. Simple in vitro translation assay to analyze inhibitors of rhinovirus proteases. Antimicrob. Agents Chemother. 40:267-270.
7. Hellen, C. U. T., M. Fäcke, H.-G. Kräusslich, C.-K. Lee, and E. Wimmer. 1991. Characterization of poliovirus 2A proteinase by mutational analysis: residues required for autocatalytic activity are essential for induction of cleavage of eukaryotic initiation factor 4F polypeptide p220. J. Virol. 65: 4226-4231.
8. Jungheim, L. N., J. D. Cohen, R. B. Johnson, E. C. Villarreal, M. Wakulchik, R. J. Loncharich, and Q. M. Wang. 1997. Inhibition of human rhinovirus 3C protease by homophthalimides. Bioorg. Med. Chem. Lett. 7:1589-1594.
9. Kaldor, S. W., M. Hammond, B. A. Dressman, J. M. Labus, F. W. Chadwell, A. D. Kline, and B. A. Heinz. 1995. Glutamine-derived aldehydes for the inhibition of human rhinovirus 3C protease. Bioorg. Med. Chem. Lett. 5:2021-2026.
10. Lamphear, B. J., R. Yan, F. Yang, D. Waters, H.-D. Liebig, H. Klump, E. Kuechler, T. Skern, and R. E. Rhoads. 1993. Mapping the cleavage site in protein synthesis initiation factor eIF-4γ of the 2A proteases from human coxsackievirus and rhinovirus. J. Biol. Chem. 268:19200-19203.
11. Liebig, H.-D., E. Ziegler, R. Yan, K. Hartmuth, H. Klump, H. Kowalski, D. Blaas, W. Sommergruber, L. Frasel, B. J. Lamphear, R. Rhoads, E. Kuechler, and T. Skern. 1993. Purification of two picornaviral 2A proteinases: interaction with eIF-4-γ and influence on in vitro translation. Biochemistry 32:7581-7588.
12. Molla, A., C. U. T. Hellen, and E. Wimmer. 1993. Inhibition of proteolytic activity of poliovirus and rhinovirus 2A proteinases by elastase-specific inhibitors. J. Virol. 67:4688-4695.
13. Palmenberg, A. C. 1990. Proteolytic procession of picornaviral polyprotein. Annu. Rev. Microbiol. 44:603-623.
14. Porter, A. G. 1993. Picornavirus nonstructural proteins: emerging roles in virus replication and inhibition of host cell functions. J. Virol. 67:6917-6921.
15. Shepherd, T. A., G. A. Cox, E. McKinney, J. Tang, M. Wakulchik, R. E. Zimmerman, and E. C. Villarreal. 1996. Small peptidic aldehyde inhibitors of human rhinovirus 3C protease. Bioorg. Med. Chem. Lett. 6:2893-2895.
16. Skern, T., W. Sommergruber, H. Auer, P. Volkmann, M. Zorn, H.-D. Liebig, F. Fessl, D. Blaas, and E. Kuechler. 1991. Substrate requirements of a human rhinoviral 2A proteinase. Virology 181:46-54.
17. Sommergruber, W., H. Ahorn, A. Zöphel, I. Maurer-Fogy, F. Fessl, G. Schnorrenberg, H.-D. Liebig, D. Blaas, E. Kuechler, and T. Skern. 1992. Cleavage specificity on synthetic peptide substrates of human rhinovirus 2 proteinase 2A. J. Biol. Chem. 267:22639-22644.
18. Wang, Q. M., R. B. Johnson, G. A. Cox, E. C. Villarreal, and R. J. Loncharich. 1997. A continuous colorimetric assay for rhinovirus-14 3C protease using p-nitroaniline peptide as substrate. Anal. Biochem. 252:238-245.
19. Wang, Q. M., W. Sommergruber, and R. B. Johnson. 1997. Cleavage specificity of human rhinovirus-2 2A protease for peptide substrates, Biochem. Biophys. Res. Commun. 235:562-566.
20. Wang, Q. M., R. B. Johnson, G. A. Cox, E. C. Villarreal, L. M. Churgay, and J. E. Hale. 1998. Enzymatic characterization of refolded human rhinovirus type 14 2A protease expressed in Escherichia coli. J. Virol. 72:1683-1687.
21. Webber, S. E., J. Tikhe, S. T. Worland, S. A. Fuhrman, T. F. Hendrickson, D. A. Matthews, R. A. Love, A. K. Patick, J. W. Meador, R. A. Ferre, E. L. Brown, D. M. DeLisle, C. E. Ford, and S. L. Binford. 1996. Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease. J. Med. Chem. 39:5072-5082.